Evidence map›Paper›PMID 42175819›Full record

SynthesisEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2026

Incidence and predictors of major arrhythmic events after myocarditis: a systematic review and meta-analysis.

Arianna Morena, Federico Giacobbe, Lorenzo Candido-Todesco, Andrea Moretti, Andrea Saglietto, Pier Paolo Bocchino, Jérôme Garot, Matteo Anselmino, Marco Merlo, Gianfranco Sinagra and 22 more

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Arianna MorenaDepartment of Medical Sciences, University of Turin, Turin, Italy.ORCID 0009-0004-7921-0234
Federico GiacobbeDepartment of Medical Sciences, University of Turin, Turin, Italy.ORCID 0000-0002-1176-4300
Lorenzo Candido-TodescoDepartment of Medical Sciences, University of Turin, Turin, Italy.ORCID 0009-0005-2644-9900
Andrea MorettiDepartment of Medical Sciences, University of Turin, Turin, Italy.ORCID 0009-0002-9605-0020
Andrea SagliettoDivision of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, Turin, Italy.ORCID 0000-0001-9475-1507
Pier Paolo BocchinoDivision of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, Turin, Italy.ORCID 0000-0001-7868-1852
Jérôme GarotInstitut Cardiovasculaire Paris Sud (ICPS), CMR Department, Hôpital Privé Jacques Cartier, Ramsay Santé, Massy, France.ORCID 0000-0003-3714-1256
Matteo AnselminoDepartment of Medical Sciences, University of Turin, Turin, Italy.ORCID 0000-0002-6311-4270
Marco MerloCenter for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy.ORCID 0000-0002-1022-3131
Gianfranco SinagraCenter for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy.ORCID 0000-0003-2700-8478
Ibrahim El-BattrawyDepartment of Cellular and Translational Physiology, Institute of Physiology, Ruhr University, Bochum 44801, Germany.ORCID 0000-0002-0139-1045
Fabrizio D'AscenzoDepartment of Medical Sciences, University of Turin, Turin, Italy.ORCID 0000-0002-6646-9317
Federico FerrarisDivision of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, Turin, Italy.ORCID 0000-0002-1557-319X
Charles GuenanciaUniversité Bourgogne Europe-CHU DIJON, service de cardiologie-PEC2 UFR Sciences de Santé, Dijon, France.
Robin NijveldtDepartment of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0003-1530-6363
Davide CastagnoDepartment of Medical Sciences, University of Turin, Turin, Italy.ORCID 0000-0001-8491-152X
Moshe Rav AchaIntegrated Heart Center, Shaare Zedek Hospital, Hebrew University, Jerusalem, Israel.ORCID 0000-0002-5365-9947
Chee Yuan NgCardiac Arrhythmia Center, Massachusetts General Hospital, Harvard University, Boston, MA, USA.ORCID 0000-0002-5568-9509
Giulia De LioDivision of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, Turin, Italy.ORCID 0009-0002-3698-194X
Filippo AngeliniDivision of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, Turin, Italy.ORCID 0000-0003-4711-0891
Simone FreaDivision of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, Turin, Italy.ORCID 0000-0002-2977-3299
Claudia RaineriDivision of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, Turin, Italy.
Guglielmo GalloneDepartment of Medical Sciences, University of Turin, Turin, Italy.ORCID 0000-0001-8011-6844
Kristian Hay KragholmDepartment of Cardiology, Aalborg University Hospital, Aalborg, Denmark.ORCID 0000-0001-9629-8670
Francesco RaveraDepartment of Medical Sciences, University of Turin, Turin, Italy.ORCID 0000-0003-4452-2591
Florent HuangACTION Study Group, Sorbonne Université, Assistance Publique-Hôpitaux de Paris, La Pitié-Salpêtrière Hospital, Department of Cardiology, Paris, France.ORCID 0000-0002-3063-1546
Mathieu KerneisACTION Study Group, Sorbonne Université, Assistance Publique-Hôpitaux de Paris, La Pitié-Salpêtrière Hospital, Department of Cardiology, Paris, France.ORCID 0000-0002-7141-5209
Gemma PelargonioDepartment of Cardiovascular Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.ORCID 0000-0003-3236-3458
Maria Lucia NarducciDepartment of Cardiovascular Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.ORCID 0000-0001-8682-0322
Massimo ImazioDepartment of Medicine, University of Udine; Cardiothoracic Department, University Hospital Santa Maria della Misericordia, ASUFC, Udine, Italy.ORCID 0000-0002-5722-0245
Gaetano Maria De FerrariDepartment of Medical Sciences, University of Turin, Turin, Italy.ORCID 0000-0003-4940-0876
Veronica DusiDepartment of Medical Sciences, University of Turin, Turin, Italy.ORCID 0000-0002-2290-3126

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsLong-term arrhythmic risk after myocarditis remains uncertain, and optimal management is debated. We aimed to assess the incidence and predictors of major arrhythmic events (MAEs) after myocarditis. METHODS AND

resultsWe conducted a systematic literature review and meta-analysis including 19 observational studies on myocarditis and MAEs during follow-up. Major arrhythmic events were defined as a composite of sudden cardiac death (SCD), ventricular fibrillation (VF), aborted cardiac arrest (ACA), sustained ventricular tachycardia (sVT), and appropriate implantable cardioverter defibrillator (ICD) or wearable-cardioverter defibrillator (WCD) intervention. The primary outcome was the incidence of MAEs after discharge; secondary outcomes included occurrence of each component of MAEs and the composite of all-cause mortality or heart transplantation (HTx). Three thousand nine hundred and fifty-four patients (71% male, 67% acute, 88% complicated myocarditis) were included. At presentation, 15% had high-grade atrioventricular block (AVB), 31% heart failure, 38% MAEs. At a median follow-up of 24 months (interquartile range 19-57), 28% suffered MAEs, with a median time of presentation of 12 months. The incidence of sVT, ACA/VF, appropriate ICD/WCD intervention, and SCD were 22%, 6%, 20%, and 1%, respectively. The combined rate of all-cause mortality/HTx was 11%. At meta-regression analysis, high-grade AVB, MAEs at presentation, and fulminant myocarditis were associated with higher risk of MAEs during follow-up, while male gender resulted as a protective factor.

conclusionThe incidence of MAEs after a complicated acute myocarditis can be high over time. Further prospective studies are needed to better stratify high-risk patients, identify those with an underlying arrhythmogenic cardiomyopathy, and guide antiarrhythmic strategies.

Indexed as

Arrhythmias, CardiacDeath, Sudden, CardiacMyocarditisAdultDefibrillators, ImplantableFemaleHumansIncidenceMaleRisk AssessmentRisk FactorsTime FactorsImplantable cardioverter defibrillatorMyocarditisVentricular arrhythmias

Identifiers

PMID42175819
PMCPMC13197844

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.